Similarly, BCL2, one of the genes whose overexpression has even been suggested to constitute a molecular marker of synovial sarcoma [48], [49], was induced in two batches of MSCs (batches 2 and 4) but not in the other two. Here, BCL2 is linked to synovial sarcoma.